$1.02 Billion is the total value of Perceptive Advisors's 120 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 80.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $76,217,000 | +10.2% | 2,558,478 | -11.1% | 7.48% | +2.9% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $68,262,000 | -8.2% | 4,599,867 | -0.4% | 6.70% | -14.3% |
| ACRX | ACELRX PHARMACEUTICALS INC | $67,384,000 | -14.7% | 6,574,060 | 0.0% | 6.61% | -20.3% | |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $44,513,000 | +8.2% | 470,142 | -19.2% | 4.37% | +1.0% |
| CELG | Buy | CELGENE CORP | $43,580,000 | +51.4% | 507,488 | +146.1% | 4.28% | +41.3% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $42,260,000 | +292.5% | 301,333 | +210.6% | 4.15% | +266.6% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $41,214,000 | +1960.7% | 12,339,444 | +1177.0% | 4.04% | +1825.2% |
| QCOR | Buy | QUESTCOR PHARMACEUTICALS INC | $36,996,000 | +1892.2% | 400,000 | +1298.6% | 3.63% | +1761.5% |
| INSM | Buy | INSMED INC | $35,964,000 | +455.5% | 1,800,000 | +429.4% | 3.53% | +418.8% |
| DYAX | Buy | DYAX CORP | $26,022,000 | +13.1% | 2,710,598 | +5.8% | 2.55% | +5.6% |
| ZBH | New | ZIMMER HLDGS INC | $25,186,000 | – | 242,500 | +100.0% | 2.47% | – |
| SHPG | Buy | SHIRE PLCsponsored adr | $21,194,000 | +375.6% | 90,000 | +200.0% | 2.08% | +344.2% |
| WAG | Sell | WALGREEN CO | $20,905,000 | +4.0% | 282,000 | -7.4% | 2.05% | -2.9% |
| XNCR | Buy | XENCOR INC | $20,226,000 | +15.8% | 1,740,621 | +16.9% | 1.98% | +8.1% |
| HRTX | Sell | HERON THERAPEUTICS INC | $20,138,000 | -17.9% | 1,634,555 | -7.3% | 1.98% | -23.3% |
| TSRO | Sell | TESARO INC | $19,816,000 | -45.4% | 636,956 | -48.2% | 1.94% | -49.0% |
| LBIO | Buy | LION BIOTECHNOLOGIES | $19,273,000 | -31.9% | 3,011,549 | +0.4% | 1.89% | -36.5% |
| NEPT | NEPTUNE TECHNOLOGIES BIORESO | $18,493,000 | +11.7% | 6,700,444 | 0.0% | 1.81% | +4.3% | |
| PTCT | PTC THERAPEUTICS INC | $17,559,000 | +0.0% | 671,736 | 0.0% | 1.72% | -6.6% | |
| OPHT | Buy | OPHTHOTECH CORP | $15,717,000 | +75.9% | 371,469 | +48.6% | 1.54% | +64.2% |
| EXAS | Sell | EXACT SCIENCES CORP | $15,348,000 | -40.7% | 901,250 | -50.6% | 1.51% | -44.6% |
| RTRX | Buy | RETROPHIN INC | $14,960,000 | -32.4% | 1,274,292 | +22.0% | 1.47% | -36.9% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $14,751,000 | -9.0% | 653,000 | -2.0% | 1.45% | -15.0% |
| MYL | Buy | MYLAN INC | $14,566,000 | +28.3% | 282,500 | +21.5% | 1.43% | +19.8% |
| RLYP | Buy | RELYPSA INC | $14,509,000 | +168.6% | 596,605 | +229.3% | 1.42% | +150.5% |
| SGMO | SANGAMO BIOSCIENCES INC | $12,216,000 | -15.5% | 800,000 | 0.0% | 1.20% | -21.2% | |
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $12,000,000 | +11.9% | 800,000 | 0.0% | 1.18% | +4.5% | |
| HCA | Buy | HCA HOLDINGS INC | $11,152,000 | +41.6% | 197,806 | +31.9% | 1.09% | +32.3% |
| PRTA | Buy | PROTHENA CORP PLC | $10,895,000 | -18.7% | 483,162 | +38.0% | 1.07% | -24.1% |
| AET | New | AETNA INC NEW | $10,646,000 | – | 131,308 | +100.0% | 1.04% | – |
| XLRN | New | ACCELERON PHARMA INC | $10,191,000 | – | 300,000 | +100.0% | 1.00% | – |
| MGNX | Sell | MACROGENICS INC | $9,383,000 | -24.9% | 431,803 | -3.8% | 0.92% | -29.9% |
| ANAC | Sell | ANACOR PHARMACEUTICALS INC | $9,375,000 | -27.6% | 528,776 | -18.3% | 0.92% | -32.4% |
| ITMN | Sell | INTERMUNE INC | $9,272,000 | +6.6% | 210,000 | -19.2% | 0.91% | -0.4% |
| VSAR | Sell | VERSARTIS INC | $8,855,000 | -41.2% | 315,796 | -37.0% | 0.87% | -45.1% |
| RCPT | Buy | RECEPTOS INC | $8,733,000 | +494.9% | 205,000 | +485.7% | 0.86% | +456.5% |
| AGN | New | ALLERGAN INC | $8,461,000 | – | 50,000 | +100.0% | 0.83% | – |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $8,449,000 | +426.7% | 700,000 | +268.4% | 0.83% | +390.5% |
| MDT | New | MEDTRONIC INC | $8,289,000 | – | 130,000 | +100.0% | 0.81% | – |
| TRXC | New | TRANSENTERIX INC | $6,552,000 | – | 1,300,000 | +100.0% | 0.64% | – |
| ARWR | Buy | ARROWHEAD RESH CORP | $6,045,000 | +16.0% | 422,406 | +33.1% | 0.59% | +8.4% |
| RGDO | New | REGADO BIOSCIENCES INC | $5,839,000 | – | 860,000 | +100.0% | 0.57% | – |
| SPNC | Sell | SPECTRANETICS CORP | $5,568,000 | -44.8% | 243,354 | -26.8% | 0.55% | -48.4% |
| ICPT | New | INTERCEPT INCput | $4,733,000 | – | 20,000 | +100.0% | 0.46% | – |
| DSCI | Sell | DERMA SCIENCES INC | $4,698,000 | -30.5% | 406,437 | -23.7% | 0.46% | -35.1% |
| CNC | Buy | CENTENE CORP DEL | $4,537,000 | +2700.6% | 60,000 | +2198.9% | 0.44% | +2517.6% |
| TRVN | TREVENA INC | $4,351,000 | -28.1% | 770,000 | 0.0% | 0.43% | -32.9% | |
| AERI | Buy | ALLIQUA | $4,196,000 | -6.4% | 1,121,951 | +430.4% | 0.41% | -12.5% |
| CPRX | New | CATALYST PHARM PARTNERS INC | $3,795,000 | – | 1,500,000 | +100.0% | 0.37% | – |
| WAG | New | WALGREEN COcall | $3,707,000 | – | 50,000 | +100.0% | 0.36% | – |
| New | ARNO THERAPEUTICS | $3,621,000 | – | 2,034,721 | +100.0% | 0.36% | – | |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $3,395,000 | – | 146,978 | +100.0% | 0.33% | – |
| CMRX | Buy | CHIMERIX INC | $3,241,000 | +1.3% | 148,000 | +5.7% | 0.32% | -5.4% |
| AEGR | New | AEGERION PHARMACEUTICALS ORDcall | $3,209,000 | – | 100,000 | +100.0% | 0.32% | – |
| TSRO | New | TESARO INCput | $3,111,000 | – | 100,000 | +100.0% | 0.30% | – |
| ZLTQ | Sell | ZELTIQ AESTHETICS INC | $3,065,000 | -73.4% | 201,628 | -65.6% | 0.30% | -75.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INCput | $2,840,000 | -86.6% | 30,000 | -90.0% | 0.28% | -87.5% |
| MGCD | Buy | MGC DIAGNOSTICS CORP | $2,652,000 | +14.8% | 316,459 | +52.9% | 0.26% | +7.0% |
| QTNT | New | QUOTIENT LTD | $2,499,000 | – | 300,000 | +100.0% | 0.24% | – |
| ACST | Sell | ACASTI PHARMA INC | $2,437,000 | -26.1% | 2,566,785 | -10.5% | 0.24% | -31.1% |
| FPRX | FIVE PRIME THERAPEUTICS INC | $2,333,000 | -20.9% | 150,000 | 0.0% | 0.23% | -26.1% | |
| F113PS | Sell | COVIDIEN PLC | $2,255,000 | -88.4% | 25,000 | -90.5% | 0.22% | -89.1% |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $2,120,000 | – | 280,000 | +100.0% | 0.21% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $2,125,000 | – | 45,643 | +100.0% | 0.21% | – |
| GNVC | GENVEC INC | $2,107,000 | -3.0% | 820,000 | 0.0% | 0.21% | -9.2% | |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $2,050,000 | – | 22,963 | +100.0% | 0.20% | – |
| UPI | Buy | UROPLASTY INC | $1,791,000 | -4.7% | 668,287 | +29.1% | 0.18% | -11.1% |
| LGND | New | LIGAND PHARMACEUTICALS INC | $1,734,000 | – | 27,843 | +100.0% | 0.17% | – |
| DRRX | DURECT CORP | $1,651,000 | +36.9% | 907,064 | 0.0% | 0.16% | +27.6% | |
| New | ANTHERA PHARMACEUTICALS INC | $1,622,000 | – | 478,456 | +100.0% | 0.16% | – | |
| CSBR | Buy | CHAMPIONS ONCOLOGY | $1,625,000 | +1.0% | 1,625,744 | +0.0% | 0.16% | -5.9% |
| OREX | New | OREXIGEN THERAPEUTICS INC | $1,384,000 | – | 224,000 | +100.0% | 0.14% | – |
| EXEL | EXELIXIS INCcall | $1,356,000 | -4.2% | 400,000 | 0.0% | 0.13% | -10.7% | |
| EPZM | Sell | EPIZYME INC | $1,326,000 | +10.7% | 42,602 | -19.0% | 0.13% | +3.2% |
| NLNK | NEWLINK GENETICS CORPcall | $1,328,000 | -6.5% | 50,000 | 0.0% | 0.13% | -12.8% | |
| AQXP | AQUINOX PHARMACEUTICALS INC | $1,218,000 | -26.4% | 130,000 | 0.0% | 0.12% | -31.6% | |
| ELOS | Sell | SYNERON MEDICAL LTD | $1,187,000 | -25.2% | 115,000 | -9.8% | 0.12% | -30.5% |
| INCY | Sell | INCYTE CORP | $1,129,000 | -88.5% | 20,000 | -89.1% | 0.11% | -89.3% |
| ATHX | Sell | ATHERSYS INC | $1,077,000 | -52.6% | 601,852 | -14.2% | 0.11% | -55.6% |
| OXGN | Sell | OXIGENE INC | $982,000 | -47.3% | 379,200 | -24.2% | 0.10% | -51.0% |
| ICAD | Sell | ICAD INC | $962,000 | -40.0% | 150,000 | -14.3% | 0.09% | -44.0% |
| ONTY | Sell | ONCOTHYREON INC | $949,000 | -41.6% | 292,779 | -46.1% | 0.09% | -45.6% |
| AKAOQ | ACHAOGEN INC | $838,000 | -9.7% | 60,000 | 0.0% | 0.08% | -16.3% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $731,000 | -15.0% | 75,000 | 0.0% | 0.07% | -20.0% | |
| BOTA | Sell | BIOTA PHARMACEUTIALS INC | $722,000 | -71.5% | 253,400 | -38.9% | 0.07% | -73.3% |
| TBIO | TRANSGENOMIC INC | $687,000 | -18.4% | 183,957 | 0.0% | 0.07% | -23.9% | |
| STEM | STEMCELLS INC | $551,000 | +51.4% | 271,600 | 0.0% | 0.05% | +42.1% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $452,000 | -96.2% | 10,917 | -93.7% | 0.04% | -96.5% |
| MDGN | Sell | MEDGENICS INC | $428,000 | 0.0% | 55,073 | -10.1% | 0.04% | -6.7% |
| BLRX | Sell | BIOLINERX LTDsponsored adr | $345,000 | -13.5% | 165,698 | -7.5% | 0.03% | -19.0% |
| HNT | Buy | HEALTH NET INC | $250,000 | +39.7% | 6,025 | +14.2% | 0.02% | +31.6% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $214,000 | – | 2,236 | +100.0% | 0.02% | – |
| ARNA | New | ARENA PHARMACEUTICALS INCput | $176,000 | – | 30,000 | +100.0% | 0.02% | – |
| RDNT | New | RADNET INC | $152,000 | – | 22,975 | +100.0% | 0.02% | – |
| SSH | New | SUNSHINE HEART INC | $140,000 | – | 25,000 | +100.0% | 0.01% | – |
| ENSG | New | ENSIGN GROUP INC | $109,000 | – | 3,509 | +100.0% | 0.01% | – |
| ICLR | New | ICON PLC | $115,000 | – | 2,440 | +100.0% | 0.01% | – |
| EXAC | New | EXACTECH INC | $113,000 | – | 4,464 | +100.0% | 0.01% | – |
| HUM | Sell | HUMANA INC | $103,000 | -27.0% | 803 | -35.8% | 0.01% | -33.3% |
| PDLI | New | PDL BIOPHARMA INC | $99,000 | – | 10,183 | +100.0% | 0.01% | – |
| MOH | New | MOLINA HEALTHCARE INC | $106,000 | – | 2,380 | +100.0% | 0.01% | – |
| PMC | New | PHARMERICA CORP | $98,000 | – | 3,441 | +100.0% | 0.01% | – |
| MRGE | New | MERGE HEALTHCARE INC | $99,000 | – | 43,478 | +100.0% | 0.01% | – |
| Q | New | QUINTILES TRANSNATIO HLDGS I | $100,000 | – | 1,875 | +100.0% | 0.01% | – |
| MDAS | New | MEDASSETS INC | $101,000 | – | 4,429 | +100.0% | 0.01% | – |
| MCK | New | MCKESSON CORP | $99,000 | – | 530 | +100.0% | 0.01% | – |
| MGLN | New | MAGELLAN HEALTH INC | $102,000 | – | 1,642 | +100.0% | 0.01% | – |
| GTIV | New | GENTIVA HEALTH SERVICES INC | $106,000 | – | 7,052 | +100.0% | 0.01% | – |
| SMA | New | SYMMETRY MED INC | $99,000 | – | 11,148 | +100.0% | 0.01% | – |
| GTS | New | TRIPLE-S MGMT CORPcl b | $105,000 | – | 5,880 | +100.0% | 0.01% | – |
| CBPO | New | CHINA BIOLOGIC PRODS INC | $107,000 | – | 2,400 | +100.0% | 0.01% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $100,000 | – | 1,860 | +100.0% | 0.01% | – |
| BSTC | New | BIOSPECIFICS TECHNOLOGIES CO | $100,000 | – | 3,700 | +100.0% | 0.01% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $97,000 | – | 1,302 | +100.0% | 0.01% | – |
| BCR | New | BARD C R INC | $97,000 | – | 676 | +100.0% | 0.01% | – |
| AFAM | New | ALMOST FAMILY INC | $104,000 | – | 4,708 | +100.0% | 0.01% | – |
| AMSG | New | AMSURG CORP | $90,000 | – | 1,980 | +100.0% | 0.01% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -38 | -100.0% | 0.00% | – |
| CBMXW | Exit | COMBIMATRIX CORPORATIONw exp 5-1-2014 | $0 | – | -5,000 | -100.0% | -0.00% | – |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -7,000 | -100.0% | -0.01% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY | $0 | – | -735 | -100.0% | -0.01% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -1,138 | -100.0% | -0.01% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -14,924 | -100.0% | -0.01% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -1,269 | -100.0% | -0.01% | – |
| OCR | Exit | OMNICARE INC | $0 | – | -1,732 | -100.0% | -0.01% | – |
| ALR | Exit | ALERE INC | $0 | – | -3,700 | -100.0% | -0.01% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -5,000 | -100.0% | -0.01% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -3,070 | -100.0% | -0.01% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS | $0 | – | -2,000 | -100.0% | -0.02% | – |
| HZNP | Exit | HORIZON PHARMA INC | $0 | – | -9,120 | -100.0% | -0.02% | – |
| MDSO | Exit | MEDIDATA SOLUTIONS INC | $0 | – | -2,802 | -100.0% | -0.02% | – |
| DVA | Exit | DAVITA HEALTHCARE PARTNERS I | $0 | – | -2,382 | -100.0% | -0.02% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -5,962 | -100.0% | -0.02% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -10,000 | -100.0% | -0.02% | – |
| CSLT | Exit | CASTLIGHT HEALTH INC | $0 | – | -8,500 | -100.0% | -0.02% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.02% | – |
| B108PS | Exit | ACTAVIS PLC | $0 | – | -945 | -100.0% | -0.02% | – |
| PTIE | Exit | PAIN THERAPEUTICS | $0 | – | -35,506 | -100.0% | -0.02% | – |
| SCAI | Exit | SURGICAL CARE AFFILIATES INC | $0 | – | -7,472 | -100.0% | -0.02% | – |
| LCI | Exit | LANNET INC | $0 | – | -6,744 | -100.0% | -0.02% | – |
| XNPT | Exit | XENOPORT INC | $0 | – | -50,000 | -100.0% | -0.03% | – |
| INSYQ | Exit | INSYS THERAPEUTICS INC NEW | $0 | – | -6,153 | -100.0% | -0.03% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -10,000 | -100.0% | -0.03% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -2,500 | -100.0% | -0.04% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -20,000 | -100.0% | -0.05% | – |
| RGEN | Exit | REPLIGEN CORPput | $0 | – | -45,000 | -100.0% | -0.06% | – |
| VVUS | Exit | VIVUS INCput | $0 | – | -100,000 | -100.0% | -0.06% | – |
| AGEN | Exit | AGENUS INC | $0 | – | -200,000 | -100.0% | -0.07% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INC | $0 | – | -45,000 | -100.0% | -0.15% | – |
| ENZ | Exit | ENZO BIOCHEM INC | $0 | – | -380,000 | -100.0% | -0.17% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -478,456 | -100.0% | -0.17% | – |
| CGEN | Exit | COMPUGEN LTDord | $0 | – | -170,000 | -100.0% | -0.19% | – |
| IDIX | Exit | IDENIX PHARMACEUTICALS INCcall | $0 | – | -300,000 | -100.0% | -0.19% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -100,000 | -100.0% | -0.20% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -31,900 | -100.0% | -0.22% | – |
| TKMR | Exit | TEKMIRA PHARMACEUTICALS CORPput | $0 | – | -100,000 | -100.0% | -0.23% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -105,900 | -100.0% | -0.25% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -220,000 | -100.0% | -0.25% | – |
| ITMN | Exit | INTERMUNE INCcall | $0 | – | -100,000 | -100.0% | -0.35% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.35% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -67,000 | -100.0% | -0.36% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -50,000 | -100.0% | -0.37% | – |
| GMED | Exit | GLOBUS MED INCcl a shrs | $0 | – | -170,000 | -100.0% | -0.48% | – |
| ARNI | Exit | ARNO THERAPEUTICS | $0 | – | -2,034,721 | -100.0% | -0.48% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -275,000 | -100.0% | -0.49% | – |
| ENZY | Exit | ENZYMOTEC LTD | $0 | – | -214,219 | -100.0% | -0.50% | – |
| CSU | Exit | CAPITAL SR LIVING CORP | $0 | – | -202,500 | -100.0% | -0.55% | – |
| ALQA | Exit | ALLIQUA | $0 | – | -784,594 | -100.0% | -0.68% | – |
| CYTK | Exit | CYTOKINETICS INCcall | $0 | – | -700,000 | -100.0% | -0.70% | – |
| CHTP | Exit | CHELSEA THERAPEUTICS INTL LT | $0 | – | -1,301,639 | -100.0% | -0.76% | – |
| SRPT | Exit | Sarepta Therapeutics Inccall | $0 | – | -350,000 | -100.0% | -0.88% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -435,000 | -100.0% | -1.09% | – |
| EXAS | Exit | EXACT SCIENCES CORPput | $0 | – | -900,000 | -100.0% | -1.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.